Original language | English (US) |
---|---|
Pages (from-to) | 243-246 |
Number of pages | 4 |
Journal | Clinical Trials |
Volume | 17 |
Issue number | 3 |
DOIs |
|
State | Published - Jun 1 2020 |
ASJC Scopus subject areas
- Pharmacology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Trials, Vol. 17, No. 3, 01.06.2020, p. 243-246.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Commentary on Bertagnolli et al.
T2 - Leveraging electronic health record data for clinical trials—a brave new world
AU - Ross, Joseph S.
AU - Dhruva, Sanket S.
AU - Shah, Nilay D.
N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. J.S.R. receives research support through Yale University from Johnson and Johnson, from the Food and Drug Administration (FDA; U01FD004585), from the Medical Devices Innovation Consortium (MDIC)/National Evaluation System for Health Technology (NEST), from the Centers of Medicare and Medicaid Services (CMS; HHSM-500-2013-13018I), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; R01HS025164), and from the Laura and John Arnold Foundation. Dr. S.S.D. receives research support from the National Heart, Lung and Blood Institute (NHLBI) of the NIH (K12HL138046) and from the Greenwall Foundation. Dr. N.D.S. receives research support through Mayo Clinic from the Centers of Medicare and Medicaid Innovation (CMMI), from the Food and Drug Administration (FDA; U01FD004585), from the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517; U19HS024075), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; R56HL130496; R01HL131535), from the Medical Devices Innovation Consortium (MDIC)/National Evaluation System for Health Technology (NEST), from the National Science Foundation, and from the Patient Centered Outcomes Research Institute (PCORI). Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. J.S.R. receives research support through Yale University from Johnson and Johnson, from the Food and Drug Administration (FDA; U01FD004585), from the Medical Devices Innovation Consortium (MDIC)/National Evaluation System for Health Technology (NEST), from the Centers of Medicare and Medicaid Services (CMS; HHSM-500-2013-13018I), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; R01HS025164), and from the Laura and John Arnold Foundation. Dr. S.S.D. receives research support from the National Heart, Lung and Blood Institute (NHLBI) of the NIH (K12HL138046) and from the Greenwall Foundation. Dr. N.D.S. receives research support through Mayo Clinic from the Centers of Medicare and Medicaid Innovation (CMMI), from the Food and Drug Administration (FDA; U01FD004585), from the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517; U19HS024075), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH; R56HL130496; R01HL131535), from the Medical Devices Innovation Consortium (MDIC)/National Evaluation System for Health Technology (NEST), from the National Science Foundation, and from the Patient Centered Outcomes Research Institute (PCORI).
PY - 2020/6/1
Y1 - 2020/6/1
UR - http://www.scopus.com/inward/record.url?scp=85083118001&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083118001&partnerID=8YFLogxK
U2 - 10.1177/1740774520913850
DO - 10.1177/1740774520913850
M3 - Comment/debate
C2 - 32266836
AN - SCOPUS:85083118001
SN - 1740-7745
VL - 17
SP - 243
EP - 246
JO - Clinical Trials
JF - Clinical Trials
IS - 3
ER -